Semnur Pharmaceuticals, Inc.
    SEC FilingsInactive

    All SEC filings by Semnur Pharmaceuticals, Inc. — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    No results found.

    Events

    No results found.

    Registrations and Prospectuses

    424B3Prospectus supplementAug 12, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffAug 12, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffAug 11, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffAug 8, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffJul 23, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffJul 2, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffJun 11, 2025
    S-4/ARegistration of securities issued in business combination transactionsView DiffApr 21, 2025
    S-4Registration of securities issued in business combination transactionsNov 6, 2024
    D$30m in Equity, Sold $6m, 5 InvestorsAug 16, 2013

    Proxies

    No results found.

    Other

    EFFECTNotice of effectivenessAug 13, 2025
    CORRESPCorrespondence with SECAug 8, 2025
    UPLOADLetter from SECAug 7, 2025
    CORRESPCorrespondence with SECJul 23, 2025
    UPLOADLetter from SECJul 16, 2025
    CORRESPCorrespondence with SECJul 2, 2025

    Ownership

    SC 13DScilex Holding Co Acquires 79.89% Stake in Semnur, Inc.Sep 26, 2025